Learning Objectives:

  1. Understand the significance of PTEN-deficiency in advanced malignancies
  2. Learn the impact of PTEN-deficiency on the tumor microenvironment
  3. Understand potential means by which PTEN-deficient malignancies evade the immune system, and consider potential interventions to manipulate those mechanisms.



  1. Review the spectrum of immune-related adverse events (irAEs)
  2. Describe the hematologic toxicities associated with immune checkpoint inhibitors (ICI) and the recommended management
  3. Discuss the potential role of ICIs in hematologic malignancies
Session date: 
10/29/2018 - 12:00pm to 1:00pm CDT
5841 South Maryland Avenue
MC2115 HemOnc Conference Room E-215
Chicago, IL 60637
United States
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Please login or create an account to proceed.
Speaker Name: 
Meghan R. Steiner, MD and Amy Wang, MD, MPH